thymosin alpha 1 dosage Used in Human Tests
What thymosin alpha 1 dosage did human tests use?
A shot leaves three plain questions: how much, how often, and for how long. Human tests give fairly clear answers about thymosin alpha 1 dosage. Written Zadaxin guides also come from its use in 35 nations. These numbers tell you what researchers tested. They do not choose a dose for you.
Which dose went into the Zadaxin guide?
Hepatitis B tests set the Zadaxin guide at 1.6 mg, given below the skin two times each week for 6 months [1][15]. Early tests found this was the lowest amount that changed T-cell blood results in most people. Researchers also estimated how much of the drug an adult thymus might make after allowing for body size. The estimate put the tested amount nearby [17]. It was an estimate, not a direct measure inside a person.
The drug leaves the blood fairly fast. About half was gone at the 2-hour mark. Blood levels were highest within 1-2 hours and fell back close to the first reading within 24 hours [17]. More shots made higher peaks but didn't keep the drug in the blood much longer. If you compare the study plans, twice weekly is the one used most often.
Which four shot plans did human papers use?
Human papers used four main plans.
1.6 mg through a shallow skin shot, two times a week. This was the most common plan. It began in hepatitis B work and also appeared in sepsis, HIV, and cancer tests [1][2][3][6][10][15]. A 6-month course was common. Some hepatitis tests ran for 12 months.
0.8 mg through a shallow skin shot, two times a week. A few tests in older or frail people used this lower amount. Some blood results changed. There aren't enough strong tests to call it a firm low-dose plan.
3.2 mg through a shallow skin shot each day, or twice daily for 7 days. Some sepsis and COVID-19 tests used this short, heavy start. One came out in 2023 [11], and an earlier sepsis test also used a heavy start [2]. A lower plan came next.
40 mcg/kg through a shallow skin shot. This means micrograms for each kilogram of a child's weight. Only a few child studies used it, so less is known about harm than in adults.
Most human tests put the needle just under the skin. A few older tests gave the drug into muscle. A vein method was discussed as unproved and was not the usual method in human care. These plans tell you what was tested, not what fits your health.
What did blood tests show after one shot?
Single shots in human tests ranged from 0.8 mg to 6.4 mg. The most common amount was 1.6 mg. After a 1.6 mg shot under the skin, blood tests found:
- About half the drug was gone in 2 hours.
- The highest blood level came 1–2 hours after the shot.
- That high point was 30–80 micrograms per liter.
- The drug reached body water around cells through much of the body. The study estimate was 30–40 liters; the shot didn't add that amount of fluid.
- Blood levels were near the start again within 24 hours [17].
The lab adds a small chemical piece to one end of the protein. That end piece slows how fast the body breaks down the drug [16]. Your own blood level was not tested here.
Why did 1.6 mg become the usual study amount?
Researchers didn't pick 1.6 mg at random. Early hepatitis B tests found it was the smallest amount that changed T-cell blood results in most people [17]. They also estimated how much thymosin alpha 1 an adult thymus might make after allowing for body size. That estimate put a 1.6 mg shot under the skin in a similar range.
The amount then went into the hepatitis B drug guide. Later tests kept using the same 1.6 mg for other illnesses. This helps you compare the results. It doesn't prove the amount is best for each illness.
How long did the human tests last?
Most tests ran 6–12 weeks, with two shots under the skin each week. Some illnesses called for a different span.
- Hepatitis B tests usually ran 6 months. Blood results kept improving after shots stopped [1].
- Hepatitis C tests paired the drug with interferon-alpha, an older virus drug, for 6 months [19].
- Sepsis tests used a heavy 7-day start, then twice-weekly shots. All care ran 4–6 weeks [2][3].
- The HIV test in people with low T cells ran 24 weeks, or 6 months [10].
- COVID-19 tests often ran 10-14 days during the severe illness [11].
Tests haven't followed steady use past 12 months well. Hepatitis work found no grave harm building up at 6 months [18]. Good human results past 12 months aren't available.
Are online dose reports the same as trial results?
What people say online isn't trial proof. People discussing thymosin alpha 1 often repeat the 1.6 mg twice-weekly plan from hepatitis B tests. They may have found it in Zadaxin drug guides. Repeating a guide doesn't turn a personal report into a controlled test.
Some people also mention 0.4–0.8 mg twice weekly, or less often, to lower cost. No controlled human test has shown that an amount below 1.6 mg still works. Forum talk can't set the amount that is safe for you.
See side effects found in human studies for what people in those tests felt.
Where did people feel thymosin alpha 1 side effects?
Most thymosin alpha 1 side effects were felt where the needle went in. People reported redness, burning, and itching. A short flu-like spell or tiredness was less common.
Drug makers and health officials collect reports from doctors and patients after a drug goes on sale. That record covers more than 600,000 treated patients [18], including people up to 101 years old, children as young as 13 months, and people with weak defenses who had many different illnesses. Unlike a set trial, the record has no matched group and may miss some problems. At the tested amounts, no clear harm to the liver, kidneys, or heart appeared.
The most common problems were:
- Redness, burning, or itching where the needle went in.
- Mild tiredness during the first days.
- A short flu-like spell in some people.
Grave problems tied to the drug were rare at the usual study amounts. The tests didn't find the bone-marrow, liver, or harsh immune trouble seen with some stronger drugs.
The large Phase 3 sepsis test included 1,106 people [4]. Its safety results looked much like the older work. That largest controlled test found no new kind of harm.
Did the main tests find grave harm?
In a 2013 sepsis test, grave health problems were much the same in both groups. Researchers didn't tie a grave problem to thymosin alpha 1 [2]. In the 2024 HIV test, people had 24 weeks of 1.6 mg twice weekly. No grave harm was tied to the drug [10]. A flu-shot test in 90 older men found no drug harm in either group [12].
There is a limit. Most controlled tests lasted only 6–24 weeks. We don't have a good test of steady use past 12 months. The 6-month hepatitis plans didn't show harm building up during follow-up [18].
Who was kept out of the tests?
There is no US drug label, so study rules give the best clue about added risk. Most tests kept out:
- People in an active flare of an illness that makes their defenses attack their own tissue.
- People with an organ transplant who took drugs to hold back their defenses.
- Pregnant people, because there was not enough safety work.
- People known to be allergic to thymalfasin or another part of the shot.
The FDA hasn't issued a final list for the US public because it hasn't approved a use. Zadaxin guides from nations where the drug is approved are the nearest formal source. Your health can change the risk, so this list can't clear you for treatment.
What do we know about long-term safety?
Hepatitis B tests lasting 6 months found no grave harm that built up over time [1][18]. The 24-week HIV test also found no grave drug harm [10]. Reports made after sale cover more than 600,000 people in 35+ nations where the drug was cleared [18]. These reports come from wide use, but they do not have the matched groups found in a trial.
Good human tests past 12 months are scarce. No test tied usual study amounts to one clear kind of organ harm. Doctors still don't know what steady long use might do when a person's defenses attack his own tissue. No controlled test has proved that worry or ruled it out.
How was the study drug kept before use?
The dry powder form of thymosin alpha 1 stayed sound at room heat when stored as the maker directed. After water was added, study guides called for 2–8 degrees C and use within 7–14 days. Light, freezing, and thawing can harm the drug.
This protein piece has no sulfur bonds holding its parts together, so air is less likely to harm it than some similar drugs. The lab also adds a small chemical piece to one end. That end piece slows breakdown in the body and in the vial [16]. Storage rules can differ by product, so the label matters.